Quick Answer
NovelStem International Corp. reported Stockholders Equity of -$2.14 million for the year ending 2025.
- NovelStem International Corp. showed an increase of +58.4% in Stockholders Equity from 2024 to 2025.
- This data is from NovelStem International Corp.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $19.92 million | Q1 2012: $14.16 million | Q3 2012: $13.15 million | Q4 2012: $24.96 million | Q1 2013: $23.92 million | Q2 2013: $23.86 million | Q3 2013: $32.07 million | Q1 2021: $3.36 million | Q2 2021: $3.24 million | Q3 2021: $2.98 million | Q1 2022: $2.25 million | Q2 2022: $2.15 million | Q3 2022: $1.93 million | Q1 2023: $1.68 million | Q2 2023: -$935.3 thousand | Q3 2023: -$2.01 million | Q1 2024: -$2.24 million | Q2 2024: -$2.54 million | Q3 2024: -$4.99 million | Q1 2025: -$5.34 million | Q2 2025: -$1.97 million | Q3 2025: -$2.05 million.
- Over the full 13 years of available data (2008 to 2025), NovelStem International Corp.'s Stockholders Equity has declined by 105.7%.
- Historical annual values: Fiscal year 2025: -$2.14 million | Fiscal year 2024: -$5.14 million | Fiscal year 2023: -$1.95 million | Fiscal year 2022: $1.93 million | Fiscal year 2022: $1.93 million | Fiscal year 2022: $2.15 million | Fiscal year 2021: $2.42 million | Fiscal year 2020: $3.49 million | Fiscal year 2012: $24.96 million | Fiscal year 2011: $14.58 million | Fiscal year 2010: $37.80 million | Fiscal year 2009: $32.47 million | Fiscal year 2008: $37.71 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: